Katzung Pharmaceuticals Private Limited, a active private limited company, was established on 27 June 2017 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999TG2017PTC117959. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 30 professional, Its leadership includes Kranthi Kumar Chintala (Additional Director), Mahesh Babu Jambuladinne (Director), Amar Vennapusa (Director). Past directors included Chintala Sirisha, Purushotham Vallepu. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 368,Raghavendra Colony Beeramguda,Patancheruvu, Hyderabad, Telangana, 502032.
U74999TG2017PTC117959
117959
27 June 2017
₹0.50 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Katzung Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kranthi Kumar Chintala | Additional Director | 08 Jul 2017 | Current |
| Mahesh Babu Jambuladinne | Director | 27 Jun 2017 | Current |
| Amar Vennapusa | Director | 27 Jun 2017 | Current |
| Syam Sundar Mukharjee Madivada | Director | 27 Jun 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Jul 2017 | Past |
| Pramod Abcsdd | Director | 10 May 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Katzung Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.62% increase. The company also saw a slight decrease in profitability, with a 0.92% decrease in profit. The company's net worth Soared by an impressive increase of 36.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Katzung Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Katzung Pharmaceuticals has a workforce of 30 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Katzung Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Katzung Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Katzung Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Katzung Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity Kranthi Kumar Chintala was appointed as a Additional Director was appointed as a Additional Director on 08 Jul 2017 & has been associated with this company since 8 years 4 months . was completed.
Progress on Mahesh Babu Jambuladinne was appointed as a Director was appointed as a Director on 27 Jun 2017 & has been associated with this company since 8 years 5 months . was documented.
The activity Amar Vennapusa was appointed as a Director was appointed as a Director on 27 Jun 2017 & has been associated with this company since 8 years 5 months . was completed.
Progress on Syam Sundar Mukharjee Madivada was appointed as a Director was appointed as a Director on 27 Jun 2017 & has been associated with this company since 8 years 5 months . was documented.
The CIN of Katzung Pharmaceuticals Private Limited is U74999TG2017PTC117959.
Katzung Pharmaceuticals Private Limited is headquartered at Plot No 368,Raghavendra Colony Beeramguda,Patancheruvu, Hyderabad, Telangana, 502032.
Katzung Pharmaceuticals Private Limited was incorporated on 27 June 2017.
The current directors of Katzung Pharmaceuticals Private Limited are
The primary industry of Katzung Pharmaceuticals Private Limited is Trade.
Katzung Pharmaceuticals Private Limited is unlisted.
The authorized capital of Katzung Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Katzung Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX